Trademark: 97111780
Word
MARENGO
Status Date
Friday, May 3, 2024
Filing Date
Friday, November 5, 2021
Published for Opposition
Tuesday, September 20, 2022
5 Pharmaceutical preparations for use in immunology and oncology; pharmaceutical preparations for use in treating cancer; pharmaceutical preparations for use in treating malignant tumors; pharmaceutical preparations for the treatment and prevention of cancer and immune system diseases and disorders; pharmaceutical preparations using antibodies to target malignant solid tumors and to promote protective tumor immunity; pharmaceutical preparations for triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; pharmaceutical preparations for immune system activation and protection; pharmaceutical preparations for anti-cancer immune activation therapeutics; pharmaceuticals, namely, antibodies for the treatment of cancer; pharmaceutical preparations for use in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; vaccines; human vaccine preparations
42 Medical and scientific research in the fields of immunology and oncology; pharmaceutical research and development; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; research and development in immunology for the purpose of using antibodies to target malignant solid tumors and to promote protective tumor immunity; research and development in pharmacology for the purpose of triggering cytokine release for the expansion of an antigen-specific memory T cell repertoire for the purpose of treating cancer; medical research services in the field of cancer; medical and scientific research in the field of cancer treatment; medical and scientific research for immune system activation and protection; research and development for the purpose of anti-cancer immune activation therapeutics; medical and scientific research in the fields of immunology and oncology for treating cancer, infectious disease, auto-immune disease, and other diseases in connection with immune system dysfunction; research and development of vaccines and medicines
Nov 9, 2021
New Application Entered
Nov 16, 2021
New Application Office Supplied Data Entered
Aug 16, 2022
Assigned To Examiner
Aug 16, 2022
Approved For Pub - Principal Register
Aug 31, 2022
Notification Of Notice Of Publication E-Mailed
Sep 20, 2022
Published For Opposition
Sep 20, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 21, 2023
Assigned To Examiner
Nov 15, 2022
Noa E-Mailed - Sou Required From Applicant
May 15, 2023
Sou Extension 1 Granted
May 15, 2023
Sou Teas Extension Received
May 15, 2023
Sou Extension 1 Filed
Oct 17, 2023
Sou Teas Extension Received
Oct 17, 2023
Sou Extension 2 Filed
Oct 17, 2023
Sou Extension 2 Granted
Oct 19, 2023
Notice Of Approval Of Extension Request E-Mailed
May 3, 2024
Sou Extension 3 Granted
May 3, 2024
Sou Teas Extension Received
May 3, 2024
Sou Extension 3 Filed
May 4, 2024
Notice Of Approval Of Extension Request E-Mailed
May 17, 2023
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
